Skip to main content
. 2015 Jan 27;59(2):859–863. doi: 10.1128/AAC.04246-14

FIG 1.

FIG 1

Bacterial counts in osseous tissue (a) and on implants (b) after a 3-week treatment period with daptomycin (DAP), fosfomycin (FOF), the daptomycin-fosfomycin combination, and no treatment in rats with experimental implant-associated MRSA osteomyelitis. Each symbol represents the value retained for an individual animal. Horizontal bars indicate median values.